Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart (Q46440282)

22 December 2017

title

Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart (English)

1 reference

22 December 2017

0 references

1 reference

Ming Zhang

1

1 reference

22 December 2017

Yan-Jun Xu

2

1 reference

22 December 2017

Harjot K Saini

3

1 reference

22 December 2017

Belma Turan

4

1 reference

22 December 2017

Peter P Liu

5

1 reference

22 December 2017

Naranjan S Dhalla

6

1 reference

22 December 2017

publication date

15 April 2005

1 reference

22 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

22 December 2017

volume

289

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

H832-9

1 reference

22 December 2017

Clinical relevance of increased retinoid and cAMP transcriptional programs in tumor cells rendered non-malignant by dominant negative inhibition of NFκB

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Molecular and cellular mechanisms of myocardial stunning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Pentoxifylline attenuates pulmonary macromolecular leakage after intestinal ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Status of myocardial antioxidants in ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Pentoxifylline reduces coronary leukocyte accumulation early in reperfusion after cold ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Human myocardial tissue TNFalpha expression following acute global ischemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Inflammatory cytokines and postmyocardial infarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Involvement of tumor necrosis factor alpha in intestinal epithelial cell proliferation following Paneth cell destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Infarct size and nitric oxide synthase in murine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Efficacy of topically applied glutamate-aspartate and pentoxifylline solutions in decreasing myocardial damage during open-heart surgery in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00178.2005

10.1152/AJPHEART.00178.2005

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017